These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18806208)

  • 1. Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccines.
    Mlambo G; Kumar N
    Eukaryot Cell; 2008 Nov; 7(11):1875-9. PubMed ID: 18806208
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate.
    Zheng W; Liu F; He Y; Liu Q; Humphreys GB; Tsuboi T; Fan Q; Luo E; Cao Y; Cui L
    Parasit Vectors; 2017 Jan; 10(1):8. PubMed ID: 28057055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicine: knockout malaria vaccine?
    Ménard R
    Nature; 2005 Jan; 433(7022):113-4. PubMed ID: 15650722
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune responses to liver-stage parasites: implications for vaccine development.
    Hollingdale MR; Krzych U
    Chem Immunol; 2002; 80():97-124. PubMed ID: 12058653
    [No Abstract]   [Full Text] [Related]  

  • 5. Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45.
    Haddad D; Maciel J; Kumar N
    Infect Immun; 2006 Apr; 74(4):2043-51. PubMed ID: 16552033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A blood stage fraction of Plasmodium berghei induces protective and long lasting immune response in BALB/c mice.
    Bagai U; Pawar A
    Parasitol Int; 2013 Jun; 62(3):329-36. PubMed ID: 23085043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.
    Douradinha B; van Dijk MR; Ataide R; van Gemert GJ; Thompson J; Franetich JF; Mazier D; Luty AJ; Sauerwein R; Janse CJ; Waters AP; Mota MM
    Int J Parasitol; 2007 Nov; 37(13):1511-9. PubMed ID: 17604034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do apoptotic Plasmodium-infected hepatocytes initiate protective immune responses?
    Renia L; Maranon C; Hosmalin A; Gruner AC; Silvie O; Snounou G
    J Infect Dis; 2006 Jan; 193(1):163-4; author reply 164-5. PubMed ID: 16323145
    [No Abstract]   [Full Text] [Related]  

  • 9. Parasitology. Malaria vaccines: back to the future?
    Waters AP; Mota MM; van Dijk MR; Janse CJ
    Science; 2005 Jan; 307(5709):528-30. PubMed ID: 15681372
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy.
    Espinosa DA; Yadava A; Angov E; Maurizio PL; Ockenhouse CF; Zavala F
    Infect Immun; 2013 Aug; 81(8):2882-7. PubMed ID: 23716612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of full-length Plasmodium falciparum P48/45 in P. berghei blood stages: A method to express and evaluate vaccine antigens.
    Othman AS; Lin JW; Franke-Fayard BM; Kroeze H; van Pul FJA; Chevalley-Maurel S; Ramesar J; Marin-Mogollon C; Jore MM; Morin MJ; Long CA; Sauerwein R; Birkett A; Miura K; Janse CJ; Khan SM
    Mol Biochem Parasitol; 2018 Sep; 224():44-49. PubMed ID: 30053393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Assessment of Transgenic Rodent Parasites for the Preclinical Evaluation of Malaria Vaccines.
    Espinosa DA; Radtke AJ; Zavala F
    Methods Mol Biol; 2016; 1403():583-601. PubMed ID: 27076155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrest in the liver--a genetically defined malaria vaccine?
    Frevert U; Nardin E
    N Engl J Med; 2005 Apr; 352(15):1600-2. PubMed ID: 15829544
    [No Abstract]   [Full Text] [Related]  

  • 14. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and immunogenicity evaluation of ectodomain and subdomains of Plasmodium berghei apical membrane antigen 1].
    Li SL; Zhang DM; Cao Y; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Feb; 25(1):1-5. PubMed ID: 17639690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic Plasmodium that expresses HIV-1 Gag elicits immunity and protects mice against vaccinia virus-gag and malarial parasites.
    Jiang B; Qin L; Du Y; Peng N; Chen L; Chen Z; Chen X
    Vaccine; 2010 Nov; 28(50):7915-22. PubMed ID: 20933565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
    Mueller AK; Labaied M; Kappe SH; Matuschewski K
    Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium berghei XAT: protective 155/160 kDa antigens are located in parasitophorous vacuoles of schizont-stage parasite.
    Kobayashi F; Waki S; Niikura M; Tachibana M; Tsuboi T; Torii M; Kamiya S
    Exp Parasitol; 2007 Aug; 116(4):450-7. PubMed ID: 17442306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium berghei merozoite surface protein-9: immunogenicity and protective efficacy using a homologous challenge model.
    Lopera-Mesa TM; Kushwaha A; Mohmmed A; Chauhan VS
    Vaccine; 2008 Mar; 26(10):1335-43. PubMed ID: 18272263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Stalled' malaria parasite becomes vaccine fodder.
    Eisenstein M
    Lab Anim (NY); 2005 Jan; 34(1):8. PubMed ID: 19795586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.